TIMM13
gene geneOn this page
Also known as Tim13
Summary
TIMM13 (translocase of inner mitochondrial membrane 13, HGNC:11816) is a protein-coding gene on chromosome 19p13.3, encoding Mitochondrial import inner membrane translocase subunit Tim13 (Q9Y5L4). Mitochondrial intermembrane chaperone that participates in the import and insertion of some multi-pass transmembrane proteins into the mitochondrial inner membrane. It is a selective cancer dependency (DepMap: 89.7% of cell lines).
This gene encodes a member of the evolutionarily conserved TIMM (translocase of inner mitochondrial membrane) family of proteins that function as chaperones in the import of proteins from the cytoplasm into the mitochondrial inner membrane. Proteins of this family play a role in collecting substrate proteins from the translocase of the outer mitochondrial membrane (TOM) complex and delivering them to either the sorting and assembly machinery in the outer mitochondrial membrane (SAM) complex or the TIMM22 complex in the inner mitochondrial membrane. The encoded protein and the translocase of mitochondrial inner membrane 8a protein form a 70 kDa complex in the intermembrane space.
Source: NCBI Gene 26517 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 25 total
- GTEx eGene: eQTL in 32 tissues, sQTL in 1 (q < 0.05)
- Cancer dependency (DepMap): dependent in 89.7% of screened cell lines
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.52 (unconstrained)
- MANE Select transcript:
NM_012458
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11816 |
| Approved symbol | TIMM13 |
| Name | translocase of inner mitochondrial membrane 13 |
| Location | 19p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Tim13 |
| Ensembl gene | ENSG00000099800 |
| Ensembl biotype | protein_coding |
| OMIM | 607383 |
| Entrez | 26517 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 13 protein_coding
MANE Select: ENST00000215570
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 5: 1
ENST00000215570, ENST00000591871, ENST00000853530, ENST00000853531, ENST00000853532, ENST00000853533, ENST00000939024, ENST00000939025, ENST00000939026, ENST00000939027, ENST00000939028, ENST00001034983, ENST00001135590
RefSeq mRNA: 1 — MANE Select: NM_012458
NM_012458
CCDS: CCDS12089
Canonical transcript exons
ENST00000215570 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000655658 | 2427256 | 2427324 |
| ENSE00001052192 | 2425625 | 2427046 |
| ENSE00001307687 | 2427414 | 2427586 |
Expression profiles
Bgee: expression breadth ubiquitous, 141 present calls, max score 97.96.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 93.0342 / max 402.4467, expressed in 1825 samples.
Highest expression (Bgee): mucosa of transverse colon, apex of heart, lower esophagus mucosa, adrenal gland, adrenal gland cortex.
Genetic regulation across tissues (GTEx eQTL / sQTL)
TIMM13 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 32 tissues and its splicing (sQTL) in 1 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
showing 20 of 33 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Esophagus Mucosa | eqtl | 1.9e-64 | -0.35 | 19:2426830:G:C |
| Skin Sun Exposed Lower leg | eqtl | 7.8e-47 | -0.25 | 19:2426830:G:C |
| Skin Not Sun Exposed Suprapubic | eqtl | 2.6e-37 | -0.27 | 19:2426830:G:C |
| Brain Cortex | eqtl | 2.3e-27 | +0.44 | 19:2426830:G:C |
| Thyroid | eqtl | 8.1e-27 | +0.19 | 19:2426830:G:C |
| Brain Frontal Cortex BA9 | eqtl | 8.7e-26 | +0.40 | 19:2426830:G:C |
| Cells Cultured fibroblasts | eqtl | 3.0e-22 | -0.30 | 19:2410444:G:A |
| Brain Hypothalamus | eqtl | 4.9e-22 | +0.45 | 19:2426830:G:C |
| Brain Caudate basal ganglia | eqtl | 1.3e-18 | +0.27 | 19:2426830:G:C |
| Brain Nucleus accumbens basal ganglia | eqtl | 4.0e-18 | +0.30 | 19:2426830:G:C |
| Brain Anterior cingulate cortex BA24 | eqtl | 1.4e-15 | +0.34 | 19:2426830:G:C |
| Pancreas | eqtl | 3.2e-14 | -0.31 | 19:2421223:T:C |
| Brain Cerebellar Hemisphere | eqtl | 6.1e-13 | +0.23 | 19:2426830:G:C |
| Brain Putamen basal ganglia | eqtl | 6.4e-13 | +0.28 | 19:2426830:G:C |
| Liver | eqtl | 1.9e-12 | -0.29 | 19:2398226:A:G |
| Heart Atrial Appendage | eqtl | 2.0e-11 | +0.17 | 19:2449945:T:C |
| Pituitary | eqtl | 1.8e-10 | +0.27 | 19:2421223:T:C |
| Brain Cerebellum | eqtl | 9.7e-10 | +0.30 | 19:2426830:G:C |
| Brain Hippocampus | eqtl | 8.4e-09 | +0.23 | 19:2426830:G:C |
| Whole Blood | eqtl | 1.0e-08 | +0.21 | 19:2418033:C:T |
FANTOM5 promoters
3 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 178166 | 83.0790 | 1823 |
| 178168 | 9.8399 | 1783 |
| 178167 | 0.1153 | 40 |
Top tissues by expression
showing 100 of 141 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 97.96 | gold quality |
| apex of heart | UBERON:0002098 | 97.22 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 97.22 | gold quality |
| right adrenal gland | UBERON:0001233 | 96.94 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 96.81 | gold quality |
| left adrenal gland | UBERON:0001234 | 96.79 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 96.71 | gold quality |
| right lobe of liver | UBERON:0001114 | 96.20 | gold quality |
| prefrontal cortex | UBERON:0000451 | 96.09 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 96.07 | gold quality |
| esophagus mucosa | UBERON:0002469 | 95.94 | gold quality |
| body of pancreas | UBERON:0001150 | 95.87 | gold quality |
| cortex of kidney | UBERON:0001225 | 95.82 | gold quality |
| metanephros cortex | UBERON:0010533 | 95.57 | gold quality |
| adrenal gland | UBERON:0002369 | 95.44 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 95.43 | gold quality |
| heart left ventricle | UBERON:0002084 | 95.09 | gold quality |
| transverse colon | UBERON:0001157 | 94.97 | gold quality |
| body of stomach | UBERON:0001161 | 94.95 | gold quality |
| frontal cortex | UBERON:0001870 | 94.89 | gold quality |
| frontal lobe | UBERON:0016525 | 94.89 | gold quality |
| substantia nigra | UBERON:0002038 | 94.87 | gold quality |
| skin of abdomen | UBERON:0001416 | 94.83 | gold quality |
| gastrocnemius | UBERON:0001388 | 94.76 | gold quality |
| skin of leg | UBERON:0001511 | 94.63 | gold quality |
| right atrium auricular region | UBERON:0006631 | 94.63 | gold quality |
| zone of skin | UBERON:0000014 | 94.51 | gold quality |
| muscle of leg | UBERON:0001383 | 94.49 | gold quality |
| muscle organ | UBERON:0001630 | 94.35 | gold quality |
| temporal lobe | UBERON:0001871 | 94.32 | gold quality |
| amygdala | UBERON:0001876 | 94.28 | gold quality |
| hypothalamus | UBERON:0001898 | 94.27 | gold quality |
| Ammon’s horn | UBERON:0001954 | 94.20 | gold quality |
| stromal cell of endometrium | CL:0002255 | 94.19 | gold quality |
| cerebral cortex | UBERON:0000956 | 94.18 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 94.09 | gold quality |
| duodenum | UBERON:0002114 | 94.05 | gold quality |
| heart | UBERON:0000948 | 93.97 | gold quality |
| esophagus | UBERON:0001043 | 93.93 | gold quality |
| fundus of stomach | UBERON:0001160 | 93.93 | gold quality |
| primary visual cortex | UBERON:0002436 | 93.91 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 93.85 | gold quality |
| left testis | UBERON:0004533 | 93.83 | gold quality |
| right testis | UBERON:0004534 | 93.82 | gold quality |
| putamen | UBERON:0001874 | 93.67 | gold quality |
| right frontal lobe | UBERON:0002810 | 93.63 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 93.60 | gold quality |
| omental fat pad | UBERON:0010414 | 93.59 | gold quality |
| prostate gland | UBERON:0002367 | 93.57 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 93.54 | gold quality |
| spleen | UBERON:0002106 | 93.52 | gold quality |
| pituitary gland | UBERON:0000007 | 93.51 | gold quality |
| right ovary | UBERON:0002118 | 93.44 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 93.43 | gold quality |
| brain | UBERON:0000955 | 93.41 | gold quality |
| left ovary | UBERON:0002119 | 93.34 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 93.33 | gold quality |
| nucleus accumbens | UBERON:0001882 | 93.32 | gold quality |
| vagina | UBERON:0000996 | 93.31 | gold quality |
| liver | UBERON:0002107 | 93.27 | gold quality |
| right uterine tube | UBERON:0001302 | 93.22 | gold quality |
| adenohypophysis | UBERON:0002196 | 93.21 | gold quality |
| placenta | UBERON:0001987 | 93.19 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 93.15 | gold quality |
| minor salivary gland | UBERON:0001830 | 93.15 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 93.09 | gold quality |
| ganglionic eminence | UBERON:0004023 | 93.04 | gold quality |
| embryo | UBERON:0000922 | 93.03 | gold quality |
| colon | UBERON:0001155 | 93.01 | gold quality |
| kidney | UBERON:0002113 | 92.92 | gold quality |
| ventricular zone | UBERON:0003053 | 92.88 | gold quality |
| caudate nucleus | UBERON:0001873 | 92.87 | gold quality |
| cortical plate | UBERON:0005343 | 92.87 | gold quality |
| thyroid gland | UBERON:0002046 | 92.86 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 92.84 | gold quality |
| stomach | UBERON:0000945 | 92.82 | gold quality |
| ovary | UBERON:0000992 | 92.80 | gold quality |
| testis | UBERON:0000473 | 92.79 | gold quality |
| adipose tissue | UBERON:0001013 | 92.49 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 92.43 | gold quality |
| small intestine | UBERON:0002108 | 92.39 | gold quality |
| left coronary artery | UBERON:0001626 | 92.37 | gold quality |
| intestine | UBERON:0000160 | 92.25 | gold quality |
| lower esophagus | UBERON:0013473 | 92.24 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 92.23 | gold quality |
| anatomical system | UBERON:0000467 | 92.21 | gold quality |
| material anatomical entity | UBERON:0000465 | 92.20 | gold quality |
| multicellular organism | UBERON:0000468 | 92.20 | gold quality |
| left uterine tube | UBERON:0001303 | 92.15 | gold quality |
| ectocervix | UBERON:0012249 | 92.09 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 92.08 | gold quality |
| granulocyte | CL:0000094 | 92.06 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 91.98 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 91.94 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 91.92 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 91.76 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 91.70 | gold quality |
| endocervix | UBERON:0000458 | 91.57 | gold quality |
| tibial nerve | UBERON:0001323 | 91.16 | gold quality |
| cerebellum | UBERON:0002037 | 91.15 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-4 | yes | 138.35 |
| E-CURD-122 | yes | 20.20 |
| E-ANND-3 | yes | 14.95 |
| E-MTAB-6075 | no | 329.02 |
| E-MTAB-7249 | no | 190.36 |
HPA expression
RNA tissue specificity: Low tissue specificity
showing 60 of 80 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Frontal cortex | tissue | 111.9 | |
| Caudate putamen | tissue | 97.5 | |
| Skeletal muscle | tissue | 71.8 | not detected |
| Vagina | tissue | 55.7 | medium |
| Pancreas | tissue | 55.3 | medium |
| Pituitary gland | tissue | 49.5 | |
| Locus coeruleus | tissue | 49.2 | |
| Choroid plexus | tissue | 48.1 | |
| Duodenum | tissue | 48.0 | medium |
| Hippocampus | tissue | 40.5 | low |
| Tongue | tissue | 39.5 | |
| Small intestine | tissue | 39.2 | medium |
| Adrenal gland | tissue | 38.0 | high |
| Nucleus accumbens | tissue | 37.1 | |
| Ovary | tissue | 36.9 | not detected |
| Salivary gland | tissue | 36.7 | medium |
| Bone marrow | tissue | 32.5 | not detected |
| Parathyroid gland | tissue | 30.4 | medium |
| Colon | tissue | 29.7 | medium |
| Postcentral gyrus | tissue | 29.3 | |
| Stomach 1 | tissue | 28.9 | high |
| Thymus | tissue | 28.9 | |
| Liver | tissue | 25.8 | medium |
| Heart muscle | tissue | 25.1 | medium |
| Appendix | tissue | 25.1 | medium |
| Lymph node | tissue | 24.8 | medium |
| Kidney | tissue | 24.7 | high |
| Placenta | tissue | 23.4 | medium |
| Spleen | tissue | 22.7 | medium |
| Skin 1 | tissue | 22.1 | medium |
| Esophagus | tissue | 21.6 | high |
| Urinary bladder | tissue | 20.8 | medium |
| Adipose tissue | tissue | 20.5 | not detected |
| Prostate | tissue | 19.0 | medium |
| Fallopian tube | tissue | 17.8 | medium |
| Testis | tissue | 17.0 | high |
| Rectum | tissue | 15.4 | medium |
| Gallbladder | tissue | 14.8 | medium |
| Tonsil | tissue | 14.6 | medium |
| Thyroid gland | tissue | 14.3 | medium |
| Endometrium 1 | tissue | 13.3 | medium |
| Breast | tissue | 13.1 | high |
| Lung | tissue | 12.7 | not detected |
| Seminal vesicle | tissue | 11.4 | medium |
| Smooth muscle | tissue | 10.9 | low |
| Corpus callosum | tissue | 10.8 | |
| Cerebral cortex | tissue | 10.7 | medium |
| Epididymis | tissue | 10.7 | medium |
| Medulla oblongata | tissue | 10.7 | |
| Temporal cortex | tissue | 10.7 | |
| Basal ganglia | tissue | 10.6 | medium |
| Putamen | tissue | 10.6 | |
| Hippocampal formation | tissue | 10.6 | |
| Insular cortex | tissue | 10.6 | |
| Pons | tissue | 10.5 | |
| Amygdala | tissue | 10.5 | |
| Spinal cord | tissue | 10.5 | |
| Septum | tissue | 10.5 | |
| Retrosplenial cortex | tissue | 10.5 | |
| Ventral forebrain | tissue | 10.4 |
Brain sub-regions (HPA Brain Atlas): detected in 191; highest nTPM — Posterior thalamic nucleus (57.9), Periaquaductal grey, anterior (51.3), Lateral geniculate body (51.1), Cerebellar nuclei (50.4), Nucleus ambiguus (49.7).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting TIMM13 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
showing 30 of 38 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-3065-3P | 99.87 | 70.25 | 1407 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-3180-5P | 99.82 | 69.12 | 2422 |
| HSA-MIR-4713-5P | 99.78 | 67.80 | 1794 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-4690-5P | 99.65 | 66.24 | 813 |
| HSA-MIR-1249-5P | 99.61 | 66.55 | 2049 |
| HSA-MIR-6797-5P | 99.61 | 66.55 | 2084 |
| HSA-MIR-1915-3P | 99.58 | 66.79 | 1988 |
| HSA-MIR-6733-3P | 99.54 | 67.80 | 1281 |
| HSA-MIR-4489 | 99.50 | 65.56 | 785 |
| HSA-MIR-330-3P | 99.41 | 69.95 | 2521 |
| HSA-MIR-4796-5P | 99.34 | 70.06 | 810 |
| HSA-MIR-488-5P | 99.28 | 68.12 | 821 |
| HSA-MIR-485-5P | 99.10 | 64.78 | 1889 |
| HSA-MIR-6884-5P | 99.10 | 64.50 | 1987 |
| HSA-MIR-4651 | 99.06 | 67.57 | 2002 |
| HSA-MIR-608 | 98.93 | 67.83 | 2013 |
| HSA-MIR-6829-5P | 98.86 | 65.12 | 1480 |
| HSA-MIR-760 | 98.81 | 66.65 | 1392 |
| HSA-MIR-6840-3P | 98.68 | 65.95 | 1923 |
| HSA-MIR-7977 | 98.65 | 66.18 | 2590 |
| HSA-MIR-4726-3P | 98.49 | 63.89 | 1385 |
| HSA-MIR-483-3P | 97.77 | 64.95 | 731 |
| HSA-MIR-3652 | 97.71 | 65.43 | 1890 |
| HSA-MIR-6783-5P | 97.67 | 67.21 | 1528 |
Functional genomics
gnomAD constraint: pLI 0.00232, LOEUF 1.52, missense Z -0.383 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000215570 — one region, missense o/e 1.11.
DepMap (CRISPR cell-line fitness): dependent in 89.7% of screened cell lines.
Most-dependent cell lines (DepMap gene-effect, lower = stronger; ≤ −0.5 shown): HPAF-II (-2.044), SF-295 (-1.899), SU-DHL-10 (-1.816), AU565 (-1.81), COLO-800 (-1.744), PANC-1 (-1.737), KE-37 (-1.717), RH-41 (-1.655), HCC1143 (-1.655), NCI-H1944 (-1.653), KELLY (-1.647), JVM-3 (-1.607), SLR 20 (-1.604), G-401 (-1.586), NCI-H82 (-1.581).
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | timm13 | ENSDARG00000058297 |
| mus_musculus | Timm13 | ENSMUSG00000020219 |
| rattus_norvegicus | Timm13 | ENSRNOG00000019682 |
| drosophila_melanogaster | Tim13 | FBGN0036204 |
| drosophila_melanogaster | CG34132 | FBGN0083968 |
| drosophila_melanogaster | CG42302 | FBGN0259198 |
| caenorhabditis_elegans | tin-13 | WBGENE00006574 |
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1353432) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 9 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| abnormal liver morphology | 1 |
| abnormal spleen morphology | 1 |
| enlarged thymus | 1 |
| abnormal seminal vesicle morphology | 1 |
| small uterus | 1 |
| enlarged kidney | 1 |
| preweaning lethality, complete penetrance | 1 |
| embryonic lethality prior to organogenesis | 1 |
| abnormal freezing behavior | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Cryptococcus deneoformans JEC21 | P0CS00 | 100.0% | Diamond |
| Cryptococcus deneoformans B-3501A | P0CS01 | 100.0% | Diamond |
| Bos taurus | Q3ZBS8 | 99.0% | Diamond |
| Xenopus laevis | Q6GPY0 | 95.8% | Diamond |
| Takifugu rubripes | Q90YI5 | 87.8% | Diamond |
| Debaryomyces hansenii CBS767 | Q6BN23 | 79.3% | Diamond |
| Kluyveromyces lactis NRRL Y-1140 | Q6CJX3 | 74.8% | Diamond |
| Eremothecium gossypii ATCC 10895 | Q75F72 | 74.8% | Diamond |
| Nakaseomyces glabratus CBS 138 | Q6FRE1 | 70.0% | Diamond |
| Saccharomyces cerevisiae S288C | P53299 | 68.8% | Diamond |
| Brugia malayi | Q9Y193 | 66.3% | Diamond |
| Candida albicans SC5314 | Q5AF54 | 63.9% | Diamond |
| Neurospora crassa OR74A | Q7SBR3 | 61.0% | Diamond |
| Fusarium graminearum PH-1 | Q4I6B0 | 60.2% | Diamond |
| Aspergillus fumigatus Af293 | Q4X0V2 | 56.8% | Diamond |
| Aspergillus nidulans FGSC A4 | Q5AZH4 | 53.8% | Diamond |
| Schizosaccharomyces pombe 972h- | Q10481 | 53.3% | Diamond |
| Oryza sativa Japonica Group | Q9XGY5 | 53.2% | Diamond |
| Mycosarcoma maydis | Q4PGT2 | 50.7% | Diamond |
| Arabidopsis thaliana | Q9XH48 | 49.4% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| MIR7108 | ncRNA | 102466806 |
| TMPRSS9 | protein-coding | 360200 |
| GADD45B | protein-coding | 4616 |
| LMNB2 | protein-coding | 84823 |
| LINC01775 | ncRNA | 101928602 |
| SPPL2B | protein-coding | 56928 |
| LSM7 | protein-coding | 51690 |
| PEAK3 | protein-coding | 374872 |
| LINGO3 | protein-coding | 645191 |
Protein
Protein identifiers
Mitochondrial import inner membrane translocase subunit Tim13 — Q9Y5L4 (reviewed: Q9Y5L4)
All UniProt accessions (2): Q9Y5L4, K7EIT2
UniProt curated annotations — full annotation on UniProt →
Function. Mitochondrial intermembrane chaperone that participates in the import and insertion of some multi-pass transmembrane proteins into the mitochondrial inner membrane. Also required for the transfer of beta-barrel precursors from the TOM complex to the sorting and assembly machinery (SAM complex) of the outer membrane. Acts as a chaperone-like protein that protects the hydrophobic precursors from aggregation and guide them through the mitochondrial intermembrane space. The TIMM8-TIMM13 complex mediates the import of proteins such as TIMM23, SLC25A12/ARALAR1 and SLC25A13/ARALAR2, while the predominant TIMM9-TIMM10 70 kDa complex mediates the import of much more proteins.
Subunit / interactions. Heterohexamer; composed of 3 copies of TIMM8 (TIMM8A or TIMM8B) and 3 copies of TIMM13, named soluble 70 kDa complex. Associates with the TIM22 complex, whose core is composed of TIMM22.
Subcellular location. Mitochondrion inner membrane.
Tissue specificity. Ubiquitous, with highest expression in heart, kidney, liver and skeletal muscle.
Domain organisation. The twin CX3C motif contains 4 conserved Cys residues that form 2 disulfide bonds in the mitochondrial intermembrane space. However, during the transit of TIMM13 from cytoplasm into mitochondrion, the Cys residues probably coordinate zinc, thereby preventing folding and allowing its transfer across mitochondrial outer membrane.
Similarity. Belongs to the small Tim family.
RefSeq proteins (1): NP_036590* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004217 | Tim10-like | Domain |
| IPR035427 | Tim10-like_dom_sf | Homologous_superfamily |
Pfam: PF02953
UniProt features (10 total): modified residue 3, sequence conflict 3, disulfide bond 2, chain 1, short sequence motif 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y5L4-F1 | 85.14 | 0.61 |
Human Protein Atlas
Protein class: Predicted intracellular proteins, Essential proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): mitochondria; nucleoli fibrillar center
Antibody reliability (HPA): IH uncertain · IF supported
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3)
| Type | Positions |
|---|---|
| N-acetylmethionine | 1 |
| Phosphoserine | 7 |
| N6-succinyllysine | 53 |
Disulfide bonds (2)
| Type | Positions |
|---|---|
| Disulfide bond | 46–69, 50–65 |
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 2; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
2 pathways:
| ID | Pathway | Evidence |
|---|---|---|
| R-HSA-1268020 | Mitochondrial protein import | electronic |
| R-HSA-9609507 | Protein localization | — |
MSigDB gene sets: 139 (showing top):
GOBP_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS, GOBP_PROTEIN_TARGETING, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE, GOCC_MITOCHONDRIAL_ENVELOPE, TIEN_INTESTINE_PROBIOTICS_24HR_UP, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_SENSORY_PERCEPTION, WONG_MITOCHONDRIA_GENE_MODULE, GOBP_MEMBRANE_ORGANIZATION, GOBP_PROTEIN_LOCALIZATION_TO_MITOCHONDRION, GOBP_PROTEIN_TARGETING_TO_MITOCHONDRION, GOBP_LOCALIZATION_WITHIN_MEMBRANE, CUI_TCF21_TARGETS_2_UP
GO Biological Process (3): sensory perception of sound (GO:0007605), protein transport (GO:0015031), protein insertion into mitochondrial inner membrane (GO:0045039)
GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (4): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial intermembrane space (GO:0005758), mitochondrial intermembrane space chaperone complex (GO:0042719)
Reactome top-level categories
1 top-level categories:
| Category | Pathways |
|---|---|
| Protein localization | 1 |
GO top-level categories
17 GO namespaces:
| Category | Terms |
|---|---|
| sensory perception of mechanical stimulus | 1 |
| transport | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| inner mitochondrial membrane organization | 1 |
| mitochondrial protein import pathway | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| mitochondrial envelope | 1 |
| organelle envelope lumen | 1 |
| mitochondrial intermembrane space | 1 |
| mitochondrial protein-containing complex | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 4 of 11 annotations. The rest are phylogenetic / computational / electronic (IEA).
4 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| protein insertion into mitochondrial inner membrane | BP | mutant phenotype |
| mitochondrial inner membrane | CC | direct assay |
| mitochondrial intermembrane space chaperone complex | CC | physical interaction |
| mitochondrion | CC | direct assay |
Protein interactions and networks
IntAct
Human interaction partners of TIMM13 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
15 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| TIMM8A | physical association | 0.740 | 3 |
| USHBP1 | physical association | 0.560 | 3 |
| MAPT | proximity | 0.420 | 1 |
| ADRM1 | physical association | 0.400 | 1 |
| CDC34 | physical association | 0.370 | 1 |
| KLF11 | physical association | 0.370 | 1 |
| OARD1 | association | 0.350 | 1 |
| CAB39 | physical association | 0.000 | 1 |
| CUL2 | physical association | 0.000 | 1 |
| EPB41 | physical association | 0.000 | 1 |
| HLA-B | physical association | 0.000 | 1 |
| MOB4 | physical association | 0.000 | 1 |
| RAD51 | physical association | 0.000 | 1 |
| RPA3 | physical association | 0.000 | 1 |
| TIMM8B | physical association | 0.000 | 1 |
BioGRID (223 interactions; top human partners by supporting records): TIMM8A (Co-fractionation; 5 records), TIMM8B (Co-fractionation; 5 records), AIFM1 (Proximity Label-MS; 3 records), MAP3K14 (Affinity Capture-MS; 3 records), PDYN (Affinity Capture-MS; 3 records), TUBG1 (Affinity Capture-MS; 3 records), C9orf173 (Affinity Capture-MS; 2 records), COX4I1 (Proximity Label-MS; 2 records), CUL3 (Affinity Capture-MS; 2 records), FGFR3 (Affinity Capture-MS; 2 records), HIST1H4A (Affinity Capture-MS; 2 records), HSF4 (Affinity Capture-Luminescence; 2 records), SFXN1 (Proximity Label-MS; 2 records), SOCS2 (Affinity Capture-MS; 2 records), SOCS6 (Proximity Label-MS; 2 records)
SIGNOR signaling
2 signaling interactions:
| A | Effect | B | Mechanism |
|---|---|---|---|
| TIMM13 | “form complex” | “TIM8A-TIM13 mitochondrial intermembrane space protein transporter complex” | binding |
| TIMM13 | “form complex” | “TIM8B-TIM13 mitochondrial intermembrane space protein transporter complex” | binding |
Protein complexes (CORUM) (1)
Experimentally-characterized complexes this protein is a subunit of (★ = the complex contains a known drug target).
1 complexes by size:
| Complex | Subunits | Members |
|---|---|---|
| TIMM8A-TIMM13 complex, mitochondrial | 2 | TIMM13, TIMM8A |
Disease & clinical
Genetic variants
Variant evidence for TIMM13: 25 ClinVar records (0 pathogenic / likely pathogenic).
ClinVar
25 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 23 |
| Likely benign | 0 |
| Benign | 1 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 25 predictions of 122):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 19:2427047 | acceptor_loss | 1.0000 | |
| 19:2427254–2427255 | donor_loss | 1.0000 | 4 |
| 19:2427412–2427413 | donor_loss | 1.0000 | 4 |
| 19:2427047–2427048 | acceptor_loss | 0.9900 | 5 |
| 19:2427254 | donor_loss | 0.9900 | |
| 19:2427325–2427326 | acceptor_loss | 0.9900 | 6 |
| 19:2427413 | donor_loss | 0.9900 | |
| 19:2427327 | acceptor_loss | 0.9800 | |
| 19:2427057 | acceptor_gain | 0.9700 | |
| 19:2427416 | donor_gain | 0.9600 |
AlphaMissense
389 missense substitutions predicted likely pathogenic (of 628 scored), across 80 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| M70 | 9 | 0.915 | 0.991 |
| D71 | 8 | 0.989 | 0.999 |
| D75 | 8 | 0.964 | 0.997 |
| D59 | 8 | 0.926 | 0.993 |
| N78 | 8 | 0.862 | 0.986 |
| M42 | 8 | 0.798 | 0.998 |
| C46 | 7 | 0.998 | 1.000 |
| F47 | 7 | 0.998 | 0.999 |
| C50 | 7 | 0.998 | 1.000 |
| C65 | 7 | 0.997 | 0.999 |
| C69 | 7 | 0.996 | 1.000 |
| W77 | 7 | 0.992 | 0.998 |
| E62 | 7 | 0.950 | 0.998 |
| M74 | 7 | 0.922 | 0.992 |
| Q36 | 7 | 0.903 | 0.999 |
| M68 | 7 | 0.891 | 0.975 |
| N34 | 7 | 0.883 | 0.992 |
| E91 | 7 | 0.874 | 0.990 |
| E37 | 7 | 0.873 | 0.989 |
| R72 | 6 | 0.996 | 1.000 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
2 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Liver Hepatocellular Carcinoma (validation) | unfavorable | 8.36e-08 |
| Liver Hepatocellular Carcinoma (TCGA) | unfavorable | 0.000463 |
Disease associations
OMIM: gene MIM:607383 | disease phenotypes:
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6066276 (SINGLE PROTEIN)
PharmGKB: 1 entry (CPIC guideline: no)
Binding affinities (BindingDB)
1 measured of 1 human assays (1 total across all organisms); most potent 1 below. Values come from heterogeneous assays and are not directly comparable.
| Ligand | Measure | Value |
|---|---|---|
| CHEMBL5653589 | KD | 1440 nM |
CTD chemical–gene interactions
39 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, increases methylation | 3 |
| Tretinoin | decreases expression | 2 |
| terbufos | increases methylation | 1 |
| sodium arsenite | decreases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| ochratoxin A | decreases expression | 1 |
| pinosylvin | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| corosolic acid | decreases expression | 1 |
| K 7174 | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | decreases expression | 1 |
| LDN 193189 | affects cotreatment, decreases expression | 1 |
| NSC 689534 | affects binding, decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Amiodarone | increases expression | 1 |
| Arsenic | decreases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Copper | affects binding, decreases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Fonofos | increases methylation | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Parathion | increases methylation | 1 |
| Piroxicam | affects cotreatment, decreases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5652630 | Binding | Binding affinity to human TIMM13 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — *ChemMedChem* |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Predicted chemistry — Sugi Predict
The predicted patent-compound landscape for TIMM13 across ~30M SureChEMBL compounds — explore on Sugi Predict.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.